256.65 0.00 (0.00%)
After hours: 4:25PM EDT
|Bid||256.50 x 900|
|Ask||257.10 x 900|
|Day's Range||256.40 - 262.72|
|52 Week Range||208.07 - 287.94|
|Beta (3Y Monthly)||0.68|
|PE Ratio (TTM)||19.29|
|Earnings Date||Oct 14, 2019 - Oct 18, 2019|
|Forward Dividend & Yield||4.32 (1.62%)|
|1y Target Est||290.23|
The Energy and Commerce Committee in the U.S. House of Representatives advanced several health care initiatives Wednesday, the most significant of which could curb surprise medical bills.
Tom Huber has steered the fund through a lot of different markets with consistent results over the past two decades. A year after the first cut, the payers in the S&P 500 were ahead of the nonpayers by 5%, they noted.
Despite a better-than-expected earnings report, the stock did not respond to the upside given uncertainty related to the 2020 election.
U.S. stocks close higher Thursday, recovering from early losses, after New York Federal Reserve President John Williams said the central bank’s wisest strategy is to cut interest rates at the first sign of economic distress when interest rates are already low.
UnitedHealth beat earnings views, but said full-year revenue might miss views. UnitedHealth stock fell after flirting with a buy point before the open.
UnitedHealth Group Inc. raised its full-year profit outlook on Thursday after reporting second-quarter earnings that topped Wall Street expectations.
UnitedHealth earnings for the second quarter of 2019 have UNH stock falling, despite positive results.Source: Shutterstock UnitedHealth (NYSE:UNH) reported earnings per share of $3.60 for the second quarter of the year. This is a roughly 15% increase over the company's earnings per share of $3.14 from the same time last year. It also comes in well above Wall Street's earnings per share estimate of $3.45 for the quarter, but UNH stock is still down today.The UnitedHealth earnings report for the second quarter of 2019 also includes net income of $3.39 billion. This is better than the company's net income of $3.01 billion reported in the second quarter of 2018.InvestorPlace - Stock Market News, Stock Advice & Trading TipsOperating income reported in the UnitedHealth earnings release for the second quarter of the year comes in at $4.74 billion. Operating income from the same period of the year prior was $4.20 billion.UnitedHealth earnings for the second quarter of 2019 has revenue coming in at $60.60 billion. That's up from the company's revenue of $56.09 billion reported in the second quarter of the previous year. This also has it beating analysts' revenue estimate of $60.59 billion for the quarter, but it couldn't stop UNH stock from falling. * 7 Stocks Top Investors Are Buying Now So why exactly is this UnitedHealth earnings report not boosting UNH stock today? It looks like it has to do with how the company beat estimates. An unexpected increase in nonoperating income contributed to it beating estimates. This doesn't have UNH shareholders stoked about the results.UNH stock was down 2% as of noon Thursday, but is up 9% year-to-date. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Stocks Top Investors Are Buying Now * The 10 Best Cryptocurrencies to Keep on Your Radar * 7 Marijuana Penny Stocks That Could Triple (But You Won't Make Money) As of this writing, William White did not hold a position in any of the aforementioned securities.The post UnitedHealth Earnings: UNH Stock Dips Despite Q2 Beat appeared first on InvestorPlace.
The Dow Jones Industrial Average midday Thursday was being yanked to session lows by a trio of components. Shares of UnitedHealth Group Inc. , Boeing Co. , and Walt Disney Co. were exacting a powerful 100-point drag on the blue-chip index, representing the lion's share of the modest declines in the price-weighted benchmark. The Dow was down 135 points, or 0.5%, at 27,089, while the S&P 500 index was sinking 0.3% lower at 2,975, with the Nasdaq Composite Index 0.5% lower at 8,143. A $1 move in any one of the Dow's components equates to a roughly 6.8-point swing in the index. UnitedHealth shares were down $6.75 at $259.90 a share, a decline of 2.5%, those for Boeing were off $5.83 to reach $363.57, a drop of 1.6%, while Disney's shares were edging 1.4% lower, off $2.03 at $140.52.
U.S. stock indexes edged lower on Thursday as investors awaited more developments around trade, while Netflix posted a surprise drop in U.S. subscribers, kicking off earnings for the FAANG group of stocks on a sour note. Losses in Netflix also dragged the communication services sector, one of the best-performing S&P sectors so far this year, 1.20% lower. "Netflix did nothing to soothe investor concerns around what earnings prospects are likely to unfold over the next couple of weeks," said Mark Luschini, chief investment strategist at Janney Montgomery Scott in Philadelphia.
A decline in shares of UnitedHealth Group Inc. Thursday morning was producing the most severe drag on the blue-chip Dow Jones Industrial Average in early action. Shares of UnitedHealth were down 1.8%, or about $4.75 lower at $261.90, translating to a roughly 30-point drag on the price-weighted Dow. The company's shares had hit a low of $257.26 near the open, representing a drag of about 50 points on the Dow. A $1 move in any one of its 30 components of the 123-year-old index equates to a 6.8-point swing. The Dow was down 18 points, or 0.1%, at 27,198. Capping the decline in the Dow was an advance in International Business Machines Corp., which was up 3.2%, delivering a roughly 30-point boost to the Dow. Meanwhile, the S&P 500 index was off 0.1% at 2,981, with a 0.2% decline for the Nasdaq Composite Index to reach 8,170. The losses for UnitedHealth come even as the health insurer reported better-than-expected quarterly results and lifted its full-year earnings outlook to $13.95 to $14.15 a share, from its previous forecast of $13.80 to $14.05. Late Wednesday, International Business Machines Corp.'s quarterly results topped estimates.
Novartis and eBay grabbed early leads Thursday as Netflix slammed the Nasdaq, even as an analyst upgrade lifted Dow Jones stock Apple toward a buy point.
UnitedHealth Group Inc will stick to its plan to implement point-of-sale rebates to all its members, Chief Executive Officer David Wichmann said on Thursday. The company is the first health insurer to report quarterly results after the Trump administration last week nixed an ambitious proposal to ban drug rebates. UnitedHealth's decisions around rebates were made independent of any pending regulations and the company's commitment to that won't change moving forward, Wichmann said on a post-earnings conference call.
"You can expect us not to change our stance on rebates," Chief Executive Officer David Wichmann said on a conference call with analysts to discuss the earnings. UnitedHealth shares were down $5.65, or 2%, at $260.94 in morning trading, after earlier rising about 1% in premarket trading on news the company beat estimates for quarterly profit and boosted its forecast for 2019 earnings. "We think UnitedHealth is underperforming the peers today likely because on the call, they guided 2019 revenues to now be 'at or slightly below' the prior revenue guidance range of $243-245 billion," Scott Fidel an analyst at Stephens said.
The health-insurance giant earned more than Wall Street expected in the second quarter and raised its forecast for the full year.
UnitedHealth (UNH) delivered earnings and revenue surprises of 4.05% and -0.12%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
UnitedHealth said it was lifting its 2019 profit outlook after reporting second-quarter earnings of $3.29 billion, or $3.42 a share, an increase from $2.92 billion, or $2.98 a share, in the year-earlier period. Revenue rose to $60.59 billion from $56.09 billion, which the company attributed to led by double-digit percentage revenue growth at UnitedHealthcare Medicare & Retirement, OptumRx and OptumHealth. On an adjusted measure, the company said it earned $3.60 a share, helped by the deferral of the health insurance tax. Analysts polled by FactSet expected earnings of $3.45 a share on revenue of $60.55 billion. The company said it was lifting its full-year adjusted EPS forecast to a range of $14.70 to $14.90, against analyst expectations of $14.70.